Tuesday, July 09, 2024 3:03:38 PM
I am certain that Draeger's Drug Test 5000 is only qualitative.
Directly from the Draeger web site - Owner's Manual:
3.3 Confirmation of results
The Dräger DrugTest 5000 test system is a qualitative measurement procedure. For a confirmed result, a second sample must be taken and analyzed
by an accredited laboratory.
Take the second sample with a collection system suitable for saliva samples.
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
It basically will tell you +/- for a specific drug. The tester has to take a second saliva sample, and ship it to a lab for further testing if +, to determine the numeric, or quantitative level. Lifeloc's device will give you a numeric reading for THC in ng/ml on site, within minutes. That reading will distinguish immediately if the subject is above, or below the legal cut-off limit for the state, country, or municipality - just like an alcohol breathalyzer would give a value, such as 0.10%.
The US Department of Transportation has established a limit of 4 ng/ml for THC. Other countries are now establishing similar cut-off limits for THC as well.
The DDT5000 is designed to be used at the roadside or after arrest, much akin to the portable breath test (PBT) devices used for alcohol testing. Unlike the PBT, the DDT5000 does not provide any numerical reading, limiting the utility of the devices to a roadside "screening" as opposed to a quantitative device. Even a positive result still requires confirmatory testing1. The DDT5000 only provides a qualitative result of a positive or negative sample, and Draeger, Inc. states in its manual that in order to obtain a confirmed analytical result, a more specific alternate chemical method is needed, such as Gas Chromatography/Mass Spectrometry. Thus, Draeger suggests that a second saliva sample be obtained and analyzed by an accredited laboratory.
Directly from the Draeger web site - Owner's Manual:
3.3 Confirmation of results
The Dräger DrugTest 5000 test system is a qualitative measurement procedure. For a confirmed result, a second sample must be taken and analyzed
by an accredited laboratory.
Take the second sample with a collection system suitable for saliva samples.
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
It basically will tell you +/- for a specific drug. The tester has to take a second saliva sample, and ship it to a lab for further testing if +, to determine the numeric, or quantitative level. Lifeloc's device will give you a numeric reading for THC in ng/ml on site, within minutes. That reading will distinguish immediately if the subject is above, or below the legal cut-off limit for the state, country, or municipality - just like an alcohol breathalyzer would give a value, such as 0.10%.
The US Department of Transportation has established a limit of 4 ng/ml for THC. Other countries are now establishing similar cut-off limits for THC as well.
The DDT5000 is designed to be used at the roadside or after arrest, much akin to the portable breath test (PBT) devices used for alcohol testing. Unlike the PBT, the DDT5000 does not provide any numerical reading, limiting the utility of the devices to a roadside "screening" as opposed to a quantitative device. Even a positive result still requires confirmatory testing1. The DDT5000 only provides a qualitative result of a positive or negative sample, and Draeger, Inc. states in its manual that in order to obtain a confirmed analytical result, a more specific alternate chemical method is needed, such as Gas Chromatography/Mass Spectrometry. Thus, Draeger suggests that a second saliva sample be obtained and analyzed by an accredited laboratory.
Recent LCTC News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/19/2026 01:05:52 PM
- Lifeloc Reports First Quarter 2026 Results and SpinDetect(TM) Development Milestone • ACCESS Newswire • 05/15/2026 10:25:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:43:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2026 09:00:17 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2026 08:36:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 08:55:07 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/27/2026 08:41:38 PM
- Lifeloc Reports 2025 Full Year Results • ACCESS Newswire • 03/27/2026 08:13:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 12:01:18 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/10/2025 05:15:06 AM
- Form AW - Amendment Withdrawal Request • Edgar (US Regulatory) • 12/04/2025 10:25:36 PM
- Form RW WD - Withdrawal of Registration Withdrawal Request • Edgar (US Regulatory) • 12/04/2025 10:24:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 10:18:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 10:15:55 PM
- Lifeloc Reports Third Quarter 2025 Results • ACCESS Newswire • 11/12/2025 09:38:00 PM
- Lifeloc to Present at Emerging Growth Conference on September 25, 2025 • ACCESS Newswire • 09/23/2025 05:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/02/2025 09:05:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2025 08:21:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2025 08:17:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2025 08:28:04 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/30/2025 04:09:15 PM
